CONX Corgenix Files Concurrent de novo 510(k) Pre-Market

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
CONX Corgenix Files Concurrent de novo 510(k) Pre-Market Notification for FDA Clearance of its Hyaluronic Acid (HA) Test Kit

Submission follows completion of NIH clinical study

Corgenix Medical Corporation (OTC BB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, announced today it has filed pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Federal Food, Drug and Cosmetic Act for its Hyaluronic Acid (HA) ELISA Test Kit.

The submission follows the completion of a clinical study conducted by Corgenix and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) under a cooperative research and development agreement (CRADA).

The study assessed the Corgenix Hyaluronic Acid (HA) Test Kit as a marker for liver fibrosis in nonalcoholic steatohepatitis (NASH) patients. NASH patients are typically diagnosed using invasive liver biopsy procedures. The Corgenix-NIDDK study was focused on developing a non-invasive method of diagnosis.

Nonalcoholic fatty liver disease (NAFLD) is a chronic, typically mild liver condition associated with obesity and insulin resistance, characterized by the presence of fat in the liver. Currently recognized as the most common cause of chronic liver disease in the U.S., NAFLD affects 20-24 percent of Americans. Nonalcoholic steatohepatitis (NASH) is an advanced form of NAFLD associated with inflammation and damage to the liver that can progress to fibrosis and cirrhosis. Approximately two to five percent of the U.S. population has NASH.

The safety and efficacy of the HA Test Kit has not yet been evaluated by the U.S. Food and Drug Administration.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases (including the world’s only non-blood-based test for aspirin effect), bone and joint disorders and a line of unique detection products for viral hemorrhagic disease. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience in product submissions to the FDA and other worldwide regulatory authorities. Additionally, Corgenix contract develops and manufactures products for key medical and life science companies in state-of-the-art facilities in Colorado. The company operates under a Quality Management System that is ISO 13485:2012 certified and compliant with FDA regulations. More information is available at www.corgenix.com.

Statements in this press release that are not strictly historical facts are “forward-looking” statements (identified by the words “believe”, “estimate”, “project”, “expect” or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company’s products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the Company’s periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon information currently known to management, and the Company does not undertake any obligation to publicly update or revise any forward-looking statements.



Company Contact:
Corgenix Medical Corp.
William Critchfield, 303-453-8903
Senior VP Operations and Finance and CFO
wcritchfield@corgenix.com
or
Media Contact:
Armada Medical Marketing
Dan Snyders, 303-623-1190 x230
Vice President and Public Relations Supervisor
dan@armadamedical.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TNBC Advocate Campaign Targets Gaps in Patient Clarity

Updated Category News Views 103

Triple-negative is a heavy phrase to hand somebody without a map. Tigerlily Foundation and the Breast Cancer Resource Center are trying to close that gap with a national education campaign scheduled to launch publicly on January 11, 2027. The plan is straightforward on paper: train and mobilize 100 patient advocates across the country to explain triple-negative breast...

Continue Reading
UTI Faces Fresh Scrutiny After Its Earnings Guidance Miss

Updated Category News Views 113

A Guidance Gap That Cannot Be Shrugged Off A $0.20-per-share hole is a nasty thing to find after management said it could see the road ahead. Universal Technical Institute reported fiscal 2026 diluted earnings per share of $0.60, below the $0.71 to $0.80 range it reaffirmed on May 6. That is at least $0.11 under the low end and roughly 21% below the midpoint. For...

Continue Reading
Why Brief Chiropractic Visits Still Need Clear Expectations

Updated Category News Views 20

A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...

Continue Reading
PBS Holiday Special Bets on Apollo 8, Music and Unity

Updated Category News Views 82

A moon mission, a 360-voice choir, and Christmas television make an unusual bundle, but that is precisely why this year’s Tabernacle Choir special has some real staying power. Peace on Earth: Christmas with The Tabernacle Choir is not trying to chase whatever noisy trend is chewing up attention this week. It is building a 90-minute holiday event around Apollo 8,...

Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now

Updated Category News Views 16

A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...

Continue Reading
Straub's Court Win Raises Cost of Seven-Year Fight

Updated Category News Views 51

Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...

Continue Reading
Bill Targets 15% Federal Goal for Women-Owned Firms

Updated Category News Views 56

Federal procurement has a stubborn habit of sounding abstract until you remember that contracts can decide whether a small company hires, invests, or simply keeps the lights on. Senator Adam Schiff introduced the Women's Economic Fairness and Small Business Contracting Act on November 19, 2026, proposing to raise the federal goal for Women-Owned Small Businesses from 5%...

Continue Reading
Green Lumber Recall Raises a Serious Safety Question

Updated Category News Views 46

A blister-pack code is doing far more work than it ever should. Green Lumber Holdings is recalling Green Lumber Natural Fuel For Men, lot GL01 with expiration 09/27, after FDA laboratory analysis confirmed undeclared tadalafil in additional samples. The company says the consumer-level recall begins November 19, 2026. This is not a cute labeling nitpick or a marketing...

Continue Reading
RBI Heads to Morgan Stanley With Plenty to Explain

Updated Category News Views 63

Two executives, one New York stage, and a short calendar gap give Restaurant Brands International a clean chance to address investors without the usual blizzard of quarterly slides. Chief Executive Officer Josh Kobza and Chief Financial Officer Sami Siddiqui are scheduled for a fireside chat at Morgan Stanley's Global Consumer & Retail Conference on December 2, 2026, at...

Continue Reading
IT Tech Packaging's Going-Concern Warning Lands Hard

Updated Category News Views 91

A paper maker can survive plenty of ugly quarters; it cannot casually shrug off an auditor questioning whether it can keep operating. That is the cold part of IT Tech Packaging's Nov. 19 disclosure. Its newly filed Form 10-K for the year ended Dec. 31, 2025 carries a “Material Uncertainty Related to Going Concern” paragraph from Audit Alliance LLP. Nobody should dress...

Continue Reading

Top 5 Most Recently Viewed Articles

InfoSync Services Partners with CogentHub for Strategic Growth

Updated Category News Views 732

InfoSync Services Partners with CogentHub for Strategic Growth In a significant move for the professional services landscape, InfoSync Services, a renowned provider of outsourced solutions, has been sold from Staple Street Capital to CogentHub. This transition marks an exciting chapter not only for InfoSync but also for its clients and the wider market. Understanding...

Continue Reading
Call for Major Economic Stimulus in China: $1.4 Trillion Boost

Updated Category News Views 211

China's Proposal for Economic Stimulus Amid global economic strains, a well-regarded former central bank adviser has put forth a notable idea: China could consider issuing ultra-long-term treasury bonds, which might generate an impressive 10 trillion yuan (around $1.4 trillion) in stimulus. This proactive suggestion was shared at the China Macroeconomy Forum and...

Continue Reading
Cavitation Technologies: Strategic Growth Plans Ahead of 2025

Updated Category News Views 261

Strategic Growth Plans for Cavitation Technologies, Inc. Cavitation Technologies, Inc. (OTCQB: CVAT) is committed to advancing its innovative capabilities in the fields of water treatment and beverage technology. As the company looks toward the future, it aims to capitalize on existing technologies while exploring new partnerships that will enhance its operations....

Continue Reading
How a $1000 Investment in Insulet Transformed Over 15 Years

Updated Category News Views 141

How Insulet Has Thrived Over the Years Insulet (NASDAQ:PODD) has shown remarkable performance, exceeding market expectations over a 15-year span with an impressive annualized return of 23.78%. This is a testament to strong financial growth, significantly outperforming many competitors. The Incredible Growth of a $1000 Investment Consider this: imagine if you invested...

Continue Reading
Synovus Executives Set to Discuss Insights at Conference

Updated Category News Views 70

Synovus Financial Corp. at the BancAnalysts Association Conference Synovus Financial Corp. (NYSE: SNV) is preparing for its participation in a highly anticipated conference that gathers financial experts and analysts. The event will feature a fireside chat with the company’s leadership, including Chairman, CEO, and President Kevin Blair along with Executive Vice...

Continue Reading